SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-20-000048
Filing Date
2020-07-29
Accepted
2020-07-28 19:18:00
Documents
79
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20200630.htm   iXBRL 10-Q 3544139
2 AMENDMENTS 2-6 TO COLLABORATION AGREEMENT WITH ASTRAZENECA amgn-ex10492020630xq2.htm EX-10.49 252119
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex312020630xq2.htm EX-31 23551
4 SECTION 1350 CERTIFICATIONS amgn-ex322020630xq2.htm EX-32 11834
  Complete submission text file 0000318154-20-000048.txt   13771431

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20200630.xsd EX-101.SCH 57713
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20200630_cal.xml EX-101.CAL 81140
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20200630_def.xml EX-101.DEF 368828
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20200630_lab.xml EX-101.LAB 679542
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20200630_pre.xml EX-101.PRE 489500
10 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20200630_htm.xml XML 3325627
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 201055220
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences